- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Sciclone Pharmaceuticals Inc+ Add to Watchlist
SCLN:US4.6500 USD 0.1100 2.42%
As of 11:19:54 ET on 04/21/2014.
Company Profile for Sciclone Pharmaceuticals Inc (SCLN)
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company's products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
Sciclone Pharmaceuticals Inc
Key Executives for Sciclone Pharmaceuticals Inc (SCLN)
|Friedhelm BlobelPresident/CEO||Hong ZhaoCEO:China Operations|
|Wilson W CheungSenior VP:Finance/CFO||Charles MengVP:Compliance/General Counsel|
|Lan XieVP:Finance/CFO:China Operations||Min YinVP:Internal Audit|